Finally, a role for CD133 cancer stem cell marker in modulation of thyroid cancer metabolism has been proposed, through CD133-dependent NF-kappaB-mediated induction of aspartate/glutamate transporter SLC1A3. Here, PROM1 is linked to cancer.